US20040006248A1 - Process for the preparation of nitroalkenes - Google Patents
Process for the preparation of nitroalkenes Download PDFInfo
- Publication number
- US20040006248A1 US20040006248A1 US10/311,319 US31131902A US2004006248A1 US 20040006248 A1 US20040006248 A1 US 20040006248A1 US 31131902 A US31131902 A US 31131902A US 2004006248 A1 US2004006248 A1 US 2004006248A1
- Authority
- US
- United States
- Prior art keywords
- process according
- nitration
- groups
- nitrite
- fluoro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 0 */C(=C/[1*])C1=CC=CC=C1.[2*]C.[3*]C.[4*]C Chemical compound */C(=C/[1*])C1=CC=CC=C1.[2*]C.[3*]C.[4*]C 0.000 description 11
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
- C07C201/06—Preparation of nitro compounds
- C07C201/08—Preparation of nitro compounds by substitution of hydrogen atoms by nitro groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/26—All rings being cycloaliphatic the ring system containing ten carbon atoms
- C07C2602/28—Hydrogenated naphthalenes
Definitions
- the present invention relates to a process for the preparation of nitroalkenes and, more particularly, it relates to a process for the preparation of conjugated ⁇ -nitroalkenes by reaction of a conjugated alkene with a nitrite in the presence of iodine and of an oxidising agent.
- Conjugated ⁇ -nitroalkenes are widely used synthetic intermediates because they can be easily converted into a variety of different compounds. For example, we can cite ⁇ -nitrostyrene, useful intermediate for the preparation of several phenylethylamines and fungicides (Chemical Abstracts, vol. 118, no.
- Wing-Wah Sy et al [Tetr. Lett., 1985, 26(9), pages 1193-1196] describe the nitration of substituted alkenes with silver nitrite and iodine, the only difference from Hassner et al being the use of a higher molar amount of silver nitrite, which is then equimolar with respect to the iodine.
- Jew et al. replace silver nitrite with sodium nitrite and use 2 moles of iodine and 4 moles of nitrite per mole of styrene, respectively.
- potassium nitrite is used in the presence of a phase transfer catalyst and by treating with ultrasounds in order to increase the solubility of the nitrite ion.
- Different amounts of iodine were evaluated to optimise the yield and the reported general method foresees the use of 2.6 moles of nitrite and 2.75 moles of iodine per mole of alkene, respectively.
- object of the present invention is a process for the nitration of conjugated alkenes of formula
- R is a hydrogen atom, an optionally substituted phenyl, a linear or branched C 1 -C 4 alkyl
- R 1 is a hydrogen atom or a linear or branched C 1 -C 4 alkyl, optionally substituted by an OH or C 1 -C 4 alkoxy group
- R 2 , R 3 and R 4 are selected among hydrogen and halogen atoms, linear or branched C 1 -C 4 alkyl or alkoxy groups, carboxylic groups, aminocarbonyl groups, alkyloxycarbonyl, alkylcarbonyl, mono- or di-alkylaminocarbonyl alkylcarbonylamino and alkylcarbonyloxy groups having from 1 to 4 carbon atoms in the alkyl moiety; or two of R 2 , R 3 and R 4 , in ortho between them, form a methylendioxy group; or R 1 together with R 2 forms a cyclic system with 5-7 terms conden
- the nitrating agent is a mixture of an inorganic nitrite and iodine in the presence of an oxidising agent.
- the nitration process object of the present invention allows to obtain ⁇ -nitroalkenes under mild conditions with good yields.
- linear or branched C 1 -C 4 alkyl means an alkyl selected among methyl, ethyl, n-propyl, isopropyl n-butyl sec-butyl isobutyl and t-butyl;
- linear or branched C 1 -C 4 alkoxy means a group selected among methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, sec-butoxy, isobutoxy and t-butoxy;
- halogen means fluorine, chlorine, bromine and iodine.
- Substituted phenyl means a phenyl substituted by one or more substituents selected among the meanings of R 2 , R 3 and R 4 .
- Preferred examples of the compounds of formula I are styrenes optionally substituted on the aromatic ring by from 1 to 3 methoxy groups or by a methylenedioxy group, dihydronaphthalenes optionally substituted by methoxy, methyl, ethyl, fluoro, chloro, bromo, iodo, carboxy, methoxycarbonyl groups or by a methylenedioxy group or benzopyranes optionally substituted by methoxy, methyl, ethyl, fluoro, chloro, bromo, iodo, carboxy, methoxycarbonyl, aminocarbonyl or methylaminocarbonyl groups.
- R 3A and R 4A are hydrogen atoms, methoxy, methyl, ethyl, fluoro, chloro, bromo, iodo, carboxy, methoxycarbonyl groups or, together, form a methylenedioxy group; R has the already reported meanings;
- R 3B and R 4B are hydrogen atoms, methoxy, methyl, ethyl, fluoro, chloro, bromo, iodo, carboxy, methoxycarbonyl, aminocarbonyl or methylaminocarbonyl groups; R has the already reported meanings;
- R, R 3A , R 3B , R 4A and R 4B have the already reported meanings.
- Examples of inorganic nitrites which can be used in the process object of the present invention are silver nitrite, sodium nitrite and potassium nitrite.
- the amount of nitrite is in excess with respect to the compound of formula I, generally not lower Man 2 moles per mole of compound to be nitrated.
- nitrite from 2 and 4 moles per mole of compound of formula I is used.
- the most characterizing feature of the present process is represented by the amount of iodine which is used.
- an oxidising agent allows to significantly decrease the amount of iodine up to an amount generally equal or lower than 1 mole per mole of compound of formula I, preferably from 0.1 and 0.8 moles per mole of substrate to be nitrated.
- the oxidation agent is slowly added, usually in 34 hours, to the reaction mixture containing the nitrite, iodine and the compound of formula I.
- AlkH represents the compound of formula I
- a further stage is represented by the fact that, by using an oxidising agent, the iodine can also be prepared in situ by oxidation of iodides.
- Iodides which can be used for such purposes are generally alkali metal iodides, preferably potassium iodide.
- oxidising agents which can be used in the process object of the present invention are peracids such as peracetic acid and m-chloroperbenzoic acid, oxygen peroxide and inorganic nitrites, optionally in admixture each other.
- the oxidising agent must be used in an acid environment, preferably at a pH lower than 5.
- the amount of oxidant will be in relation to the used amount of iodine, preferably in slight excess.
- a higher amount of oxidant will be needed to allow the initial oxidation of the iodides
- the process object of the present invention is carried out in the presence of a suitable organic solvent which is selected in relation to the solubility of the compound of formula I but which is not a critical parameter for the achievement of the process.
- esters such as ethyl acetate, isopropyl acetate and isobutyl acetate
- aromatic hydrocarbons such as toluene and xylene
- chlorinated hydrocarbons such as methylene chloride and 1,2-dichloropropane
- ethers such as tert-butyl methyl ether.
- reaction mixture contains water
- addition of a phase transfer catalyst can be. useful.
- the temperature is not a critical parameter. Preferably temperatures from 20° C. to 70° C. are used. A still more preferred temperature range is from 40° C. to 50° C.
- a preferred embodiment of the process object of the present invention is the following.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pyrane Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/247,600 US7265251B2 (en) | 2000-06-28 | 2005-10-12 | Process for the preparation of nitroalkenes |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00830453.7 | 2000-06-28 | ||
EP00830453 | 2000-06-28 | ||
PCT/EP2001/006902 WO2002000575A1 (en) | 2000-06-28 | 2001-06-19 | Process for the preparation of nitroalkenes |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/247,600 Continuation US7265251B2 (en) | 2000-06-28 | 2005-10-12 | Process for the preparation of nitroalkenes |
Publications (1)
Publication Number | Publication Date |
---|---|
US20040006248A1 true US20040006248A1 (en) | 2004-01-08 |
Family
ID=8175386
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/311,319 Abandoned US20040006248A1 (en) | 2000-06-28 | 2001-06-19 | Process for the preparation of nitroalkenes |
US11/247,600 Expired - Fee Related US7265251B2 (en) | 2000-06-28 | 2005-10-12 | Process for the preparation of nitroalkenes |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/247,600 Expired - Fee Related US7265251B2 (en) | 2000-06-28 | 2005-10-12 | Process for the preparation of nitroalkenes |
Country Status (12)
Country | Link |
---|---|
US (2) | US20040006248A1 (zh) |
EP (1) | EP1294658B1 (zh) |
JP (1) | JP4705307B2 (zh) |
CN (1) | CN1232480C (zh) |
AT (1) | ATE289986T1 (zh) |
AU (1) | AU2001278456A1 (zh) |
CA (1) | CA2412232C (zh) |
DE (1) | DE60109163T2 (zh) |
DK (1) | DK1294658T3 (zh) |
ES (1) | ES2239155T3 (zh) |
PT (1) | PT1294658E (zh) |
WO (1) | WO2002000575A1 (zh) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100331268A1 (en) * | 2004-04-28 | 2010-12-30 | The Uab Research Foundation | Nitrated Lipids and Methods of Making and Using Thereof |
US8563609B2 (en) | 2010-05-13 | 2013-10-22 | Nitromega Corp. | Nitro fatty acids - neuroprotection and/or inhibition of cognitive decline |
US9585855B2 (en) | 2008-06-19 | 2017-03-07 | The University Of Utah Research Foundation | Use of nitrated lipids for treatment of side effects of toxic medical therapies |
US9663444B2 (en) | 2009-10-02 | 2017-05-30 | Complexa, Inc. | Heteroatom containing substituted fatty acids |
US9700534B2 (en) | 2007-08-01 | 2017-07-11 | University of Pittsburgh—of the Commonwealth System of Higher Education | Nitrated-fatty acids modulation of type II diabetes |
US9750725B2 (en) | 2009-07-31 | 2017-09-05 | University of Pittsburgh—of the Commonwealth System of Higher Education | Fatty acids as anti-inflammatory agents |
US9790167B2 (en) | 2008-05-01 | 2017-10-17 | Complexa, Inc. | Vinyl substituted fatty acids |
US10010532B2 (en) | 2011-08-19 | 2018-07-03 | The University Of Utah Research Foundation | Combination therapy with nitrated lipids and inhibitors of the renin-angiotensin-aldosterone system |
US10369125B2 (en) | 2008-06-19 | 2019-08-06 | The University Of Utah Research Foundation | Method of treating renal system damage |
US10537541B2 (en) | 2015-10-02 | 2020-01-21 | Complexa Inc. | Treatment of focal segmental glomerular sclerosis (FSGS) using therapeutically effective oral doses of 10-nitro-9(E)-octadec-9-enoic acid |
US11608342B2 (en) | 2015-07-07 | 2023-03-21 | H. Lundbeck A/S | PDE9 inhibitors with imidazo triazinone backbone and imidazo pyrazinone backbone for treatment of peripheral diseases |
US12006319B2 (en) | 2018-05-25 | 2024-06-11 | Cardurion Pharmaceuticals, Inc. | Monohydrate and crystalline forms of 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7H-imidazo[1,5-a]pyrazin-8-one |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102574768B (zh) * | 2009-10-20 | 2015-07-08 | 安格斯化学公司 | 用于通过将水相再循环至硝化反应器以回收硝基烷烃的方法 |
FR2985999B1 (fr) | 2012-01-23 | 2014-01-31 | Arkema France | Procede de production d'acrylate de 2-octyle par transesterification |
CN105152935A (zh) * | 2015-09-06 | 2015-12-16 | 安徽理工大学 | 一种制备β-硝基苯乙烯类化合物的方法 |
CN107032939B (zh) * | 2017-05-17 | 2020-09-11 | 沅江华龙催化科技有限公司 | α,β-不饱和硝基烯烃衍生物的合成方法 |
CN106995373B (zh) * | 2017-05-17 | 2019-01-11 | 沅江华龙催化科技有限公司 | 以碘化铵为硝基源一锅合成α,β-不饱和硝基烯烃衍生物的方法 |
CN106995372B (zh) * | 2017-05-17 | 2018-12-18 | 沅江华龙催化科技有限公司 | 一种基于四芳基卟啉铁催化合成(E)-β-硝基苯乙烯衍生物的方法 |
CN107098811B (zh) * | 2017-05-17 | 2019-03-26 | 沅江华龙催化科技有限公司 | (E)-β-硝基苯乙烯的合成方法 |
CN109970701B (zh) * | 2019-04-02 | 2021-05-04 | 常州大学 | 一种用I2O5/NaNO2硝化富电子芳香族化合物的方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9701438D0 (sv) * | 1997-04-17 | 1997-04-17 | Astra Ab | A new process |
-
2001
- 2001-06-19 EP EP01956483A patent/EP1294658B1/en not_active Expired - Lifetime
- 2001-06-19 AU AU2001278456A patent/AU2001278456A1/en not_active Abandoned
- 2001-06-19 PT PT01956483T patent/PT1294658E/pt unknown
- 2001-06-19 US US10/311,319 patent/US20040006248A1/en not_active Abandoned
- 2001-06-19 DK DK01956483T patent/DK1294658T3/da active
- 2001-06-19 WO PCT/EP2001/006902 patent/WO2002000575A1/en active IP Right Grant
- 2001-06-19 JP JP2002505326A patent/JP4705307B2/ja not_active Expired - Fee Related
- 2001-06-19 ES ES01956483T patent/ES2239155T3/es not_active Expired - Lifetime
- 2001-06-19 CA CA2412232A patent/CA2412232C/en not_active Expired - Lifetime
- 2001-06-19 CN CNB018116868A patent/CN1232480C/zh not_active Expired - Fee Related
- 2001-06-19 AT AT01956483T patent/ATE289986T1/de active
- 2001-06-19 DE DE60109163T patent/DE60109163T2/de not_active Expired - Lifetime
-
2005
- 2005-10-12 US US11/247,600 patent/US7265251B2/en not_active Expired - Fee Related
Cited By (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9867795B2 (en) | 2004-04-28 | 2018-01-16 | The Uab Research Foundation | Nitrated lipids and methods of making and using thereof |
US8309526B2 (en) | 2004-04-28 | 2012-11-13 | The Uab Research Foundation | Nitrated lipids and methods of making and using thereof |
US9006473B2 (en) | 2004-04-28 | 2015-04-14 | The Uab Research Foundation | Nitrated lipids and methods of making and using thereof |
US9295678B2 (en) | 2004-04-28 | 2016-03-29 | The Uab Research Foundation | Nitrated lipids and methods of making and using thereof |
US9522156B2 (en) | 2004-04-28 | 2016-12-20 | The Uab Research Foundation | Nitrated lipids and methods of making and using thereof |
US20100331268A1 (en) * | 2004-04-28 | 2010-12-30 | The Uab Research Foundation | Nitrated Lipids and Methods of Making and Using Thereof |
US10869850B2 (en) | 2007-08-01 | 2020-12-22 | University of Pittsburgh—of the Commonwealth System of Higher Education | Nitrated-fatty acids modulation of type II diabetes |
US10576051B2 (en) | 2007-08-01 | 2020-03-03 | University of Pittsburgh—of the Commonwealth System of Higher Education | Nitrated-fatty acids modulation of type II diabetes |
US9700534B2 (en) | 2007-08-01 | 2017-07-11 | University of Pittsburgh—of the Commonwealth System of Higher Education | Nitrated-fatty acids modulation of type II diabetes |
US10258589B2 (en) | 2007-08-01 | 2019-04-16 | University of Pittsburgh—of the Commonwealth System of Higher Education | Nitrated-fatty acids modulation of type II diabetes |
US9790167B2 (en) | 2008-05-01 | 2017-10-17 | Complexa, Inc. | Vinyl substituted fatty acids |
US9585855B2 (en) | 2008-06-19 | 2017-03-07 | The University Of Utah Research Foundation | Use of nitrated lipids for treatment of side effects of toxic medical therapies |
US10369125B2 (en) | 2008-06-19 | 2019-08-06 | The University Of Utah Research Foundation | Method of treating renal system damage |
US10568857B2 (en) | 2008-06-19 | 2020-02-25 | The University Of Utah Research Foundation | Method of treating renal system damage |
US10835518B2 (en) | 2009-07-31 | 2020-11-17 | University of Pittsburgh—of the Commonwealth System of Higher Education | Fatty acids as anti-inflammatory agents |
US10213417B2 (en) | 2009-07-31 | 2019-02-26 | University of Pittsburgh—of the Commonwealth System of Higher Education | Fatty acids as anti-inflammatory agents |
US9750725B2 (en) | 2009-07-31 | 2017-09-05 | University of Pittsburgh—of the Commonwealth System of Higher Education | Fatty acids as anti-inflammatory agents |
US11723897B2 (en) | 2009-07-31 | 2023-08-15 | University of Pittsburgh—of the Commonwealth System of Higher Education | Fatty acids as anti-inflammatory agents |
US9663444B2 (en) | 2009-10-02 | 2017-05-30 | Complexa, Inc. | Heteroatom containing substituted fatty acids |
US8563609B2 (en) | 2010-05-13 | 2013-10-22 | Nitromega Corp. | Nitro fatty acids - neuroprotection and/or inhibition of cognitive decline |
US10709690B2 (en) | 2011-08-19 | 2020-07-14 | The University Of Utah Research Foundation | Combination therapy with nitrated lipids and inhibitors of the renin-angiotensin-aldosterone system |
US10010532B2 (en) | 2011-08-19 | 2018-07-03 | The University Of Utah Research Foundation | Combination therapy with nitrated lipids and inhibitors of the renin-angiotensin-aldosterone system |
US11608342B2 (en) | 2015-07-07 | 2023-03-21 | H. Lundbeck A/S | PDE9 inhibitors with imidazo triazinone backbone and imidazo pyrazinone backbone for treatment of peripheral diseases |
US10537541B2 (en) | 2015-10-02 | 2020-01-21 | Complexa Inc. | Treatment of focal segmental glomerular sclerosis (FSGS) using therapeutically effective oral doses of 10-nitro-9(E)-octadec-9-enoic acid |
US12006319B2 (en) | 2018-05-25 | 2024-06-11 | Cardurion Pharmaceuticals, Inc. | Monohydrate and crystalline forms of 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7H-imidazo[1,5-a]pyrazin-8-one |
Also Published As
Publication number | Publication date |
---|---|
DK1294658T3 (da) | 2005-06-27 |
US20060063953A1 (en) | 2006-03-23 |
ATE289986T1 (de) | 2005-03-15 |
US7265251B2 (en) | 2007-09-04 |
PT1294658E (pt) | 2005-07-29 |
CN1438977A (zh) | 2003-08-27 |
CN1232480C (zh) | 2005-12-21 |
CA2412232A1 (en) | 2002-01-03 |
AU2001278456A1 (en) | 2002-01-08 |
EP1294658A1 (en) | 2003-03-26 |
DE60109163D1 (de) | 2005-04-07 |
JP2004501878A (ja) | 2004-01-22 |
DE60109163T2 (de) | 2006-04-13 |
WO2002000575A1 (en) | 2002-01-03 |
EP1294658B1 (en) | 2005-03-02 |
ES2239155T3 (es) | 2005-09-16 |
JP4705307B2 (ja) | 2011-06-22 |
CA2412232C (en) | 2010-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7265251B2 (en) | Process for the preparation of nitroalkenes | |
IL209691A (en) | Biphenyl is converted | |
CN111662240B (zh) | 一种高纯度丙硫菌唑的制备方法 | |
EP0031253B1 (en) | Process for preparing 3,4-substituted benzaldehydes | |
ZA200101507B (en) | Method for producing ortho-alkylated benzoic acid derivatives. | |
US5777172A (en) | Process for the preparation of benzophenthiones and benzophenones | |
JP2009137955A (ja) | シクロアルキルおよびハロアルキルo−アミノフエニルケトン類の改良された製造方法 | |
JP4550492B2 (ja) | フッ素含有アセトフェノンの製造方法およびその使用 | |
US6943257B2 (en) | Process for preparation of aromatic halides from aromatic amines | |
JP3663229B2 (ja) | 4−ハロ−2′−ニトロブチロフエノン化合物の製造方法 | |
EP1295864B1 (en) | Process for preparation of 1,5-diaminonaphthalenes | |
Genin et al. | Gold catalysis in organic synthesis: efficient intramolecular cyclization of γ-acetylenic carboxylic acids to 5-exo-alkylidene-butyrolactones | |
KR100353536B1 (ko) | 치환된페닐아세트산유도체의제조방법및신규한중간체 | |
CH589591A5 (en) | Aryl-alkane acids production - forming an aldehyde from aryl or alkyl groupings and converting | |
EP1870392B1 (en) | Process for production of 2,3,4-trifluoro-5-(iodo or bromo)benzoic acid | |
US6121491A (en) | Process for the preparation of (+/-)3-(3,4-dichlorophenyl)-2-dimethylamino-2-methylpropan-1-OL or cericlamine (INN) | |
WO2023080193A1 (ja) | インドール化合物の製造方法 | |
EP1638909A2 (en) | Process for preparing alkoxy- and aryloxy-phenols | |
JP3765394B2 (ja) | 水中アルドール反応方法 | |
JPH08169868A (ja) | 4−シアノ−4’−ヒドロキシビフェニルの製造方法 | |
JP2547089B2 (ja) | カルボン酸類の製法 | |
CN111592465A (zh) | 一种制备2-氨基-4-氨甲基苯甲酸甲酯及其盐酸盐的方法 | |
IE780470L (en) | Benzylidene halides | |
JPH11255720A (ja) | 芳香族アミンの製造方法 | |
JPH07103069B2 (ja) | β−アセトナフトンの選択的製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: ZAMBON GROUP S.P.A., ITALY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:PAIOCCHI, MAURIZIO;BELLI, ALDO;PONZINI, FRANCESCO;AND OTHERS;REEL/FRAME:013725/0268;SIGNING DATES FROM 20021021 TO 20021125 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: ZACH SYSTEM S.P.A., ITALY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ZAMBON GROUP S.P.A.;REEL/FRAME:019649/0001 Effective date: 20070101 |